These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

937 related items for PubMed ID: 16242565

  • 21. [Local applied slow-releasing rapamycin inhibits neointima hyperplasia in vein graft].
    Zhang LF, Xiao F, Li J, Wang J, Shi ZH, Li CY.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1706-9. PubMed ID: 16854327
    [Abstract] [Full Text] [Related]

  • 22. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
    Gulkarov I, Bohmann K, Cinnante KM, Pirelli L, Yu PJ, Grau JB, Pintucci G, Galloway AC, Mignatti P.
    J Surg Res; 2009 Jun 01; 154(1):150-6. PubMed ID: 18805551
    [Abstract] [Full Text] [Related]

  • 23. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
    Davies MG, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen PO.
    Surgery; 1994 Sep 01; 116(3):557-68. PubMed ID: 8079186
    [Abstract] [Full Text] [Related]

  • 24. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
    Déglise S, Martin D, Probst H, Saucy F, Hayoz D, Waeber G, Nicod P, Ris HB, Corpataux JM, Haefliger JA.
    J Vasc Surg; 2005 Jun 01; 41(6):1043-52. PubMed ID: 15944608
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway.
    Sugimoto M, Yamanouchi D, Komori K.
    Surg Today; 2009 Jun 01; 39(6):459-65. PubMed ID: 19468800
    [Abstract] [Full Text] [Related]

  • 26. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
    Saunders PC, Pintucci G, Bizekis CS, Sharony R, Hyman KM, Saponara F, Baumann FG, Grossi EA, Colvin SB, Mignatti P, Galloway AC.
    J Thorac Cardiovasc Surg; 2004 May 01; 127(5):1276-84. PubMed ID: 15115983
    [Abstract] [Full Text] [Related]

  • 27. [Experimental study on rho-kinase inhibitor by intravenous injection inhibiting intimal hyperplasia in vein grafts].
    Zheng Z, Pan J, Ma L, Yu X, Guo M, Yao S.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Sep 01; 23(9):1110-3. PubMed ID: 19817300
    [Abstract] [Full Text] [Related]

  • 28. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H, Mii S, Enomoto A, Murakumo Y, Kato T, Asai N, Komori K, Takahashi M.
    J Vasc Surg; 2014 Aug 01; 60(2):479-489.e5. PubMed ID: 23948670
    [Abstract] [Full Text] [Related]

  • 29. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD, Dassow MS, Seabrook GR, Jean-Claude JM, Towne JB, Cambria RA.
    J Surg Res; 2000 May 15; 90(2):183-90. PubMed ID: 10792961
    [Abstract] [Full Text] [Related]

  • 30. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
    Kozai T, Eto M, Yang Z, Shimokawa H, Lüscher TF.
    Cardiovasc Res; 2005 Dec 01; 68(3):475-82. PubMed ID: 16098957
    [Abstract] [Full Text] [Related]

  • 31. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Petrofski JA, Hata JA, Williams ML, Parsa CJ, Thompson RB, Hanish SI, Gehrig TR, Koch WJ, Milano CA.
    J Thorac Cardiovasc Surg; 2005 Dec 01; 130(6):1683-90. PubMed ID: 16308016
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
    Ehsan A, Mann MJ, Dell'Acqua G, Dzau VJ.
    J Thorac Cardiovasc Surg; 2001 Apr 01; 121(4):714-22. PubMed ID: 11279413
    [Abstract] [Full Text] [Related]

  • 36. [Experimental studies on effect of grafting injury to vein graft].
    Yao S, Zhang Y, Tian D.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct 01; 20(10):1021-5. PubMed ID: 17140079
    [Abstract] [Full Text] [Related]

  • 37. The temporal sequence of G-protein expression in intimal hyperplasia.
    Davies MG, Barber L, Dhanraj DN, Gettys TW, Ramkumar V, Hagen PO.
    J Surg Res; 1996 Jun 01; 63(1):115-22. PubMed ID: 8661183
    [Abstract] [Full Text] [Related]

  • 38. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
    Vijayan V, Shukla N, Johnson JL, Gadsdon P, Angelini GD, Smith FC, Baird R, Jeremy JY.
    J Vasc Surg; 2004 Nov 01; 40(5):1011-9. PubMed ID: 15557918
    [Abstract] [Full Text] [Related]

  • 39. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA, Jiang Z, Klingman NV, Pfahnl CL, Abouhamze ZS, Frase CD, Schultz GS, Ozaki CK.
    J Vasc Surg; 2004 May 01; 39(5):1084-90. PubMed ID: 15111865
    [Abstract] [Full Text] [Related]

  • 40. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J, Zhang X, Yang H, Zhu Y, Ma H, Wang S.
    Ann Vasc Surg; 2011 May 01; 25(4):538-46. PubMed ID: 21549923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.